Cargando…

Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease”

Detalles Bibliográficos
Autores principales:	Macaluso, Fabio Salvatore, Orlando, Ambrogio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617624/ http://dx.doi.org/10.1016/j.dld.2022.09.021

Ejemplares similares

Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2021)

Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2020)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
por: Alexander, James L, et al.
Publicado: (2021)

Head-to-head comparison of biological drugs for inflammatory bowel disease: from randomized controlled trials to real-world experience
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2021)

Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
por: Zingone, Fabiana, et al.
Publicado: (2020)

Reply to ‘Comment on “The myth of pulmonary metastasectomy’”
por: Macbeth, Fergus, et al.
Publicado: (2020)

A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant
por: Toya, Takashi, et al.
Publicado: (2022)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
por: Alexander, James L, et al.
Publicado: (2021)

Reply to ‘Comment on ‘Circulating Neutrophils in patients with hepatocellular carcinoma”
por: Chan, Stephen L., et al.
Publicado: (2018)

Reply to ‘Comment on “Tumour-agnostic drugs in paediatric cancers”’
por: Chisholm, Julia C., et al.
Publicado: (2020)

Authors’ reply to the comment from Uchida et al.
por: Osawa, Itsuki, et al.
Publicado: (2023)

Authors’ reply to the comment from Glass et al.
por: Kotani, Yuki, et al.
Publicado: (2023)

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients
por: Khan, Qamar J., et al.
Publicado: (2022)

Comment on “Heterologous adenovirus‐vector/messenger RNA regimen, humoral response and liver transplant recipients”
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease
por: Wellens, Judith, et al.
Publicado: (2022)

The Author Reply: A Comment on “Quaternary Prevention in Public Health”
por: Bae, Jong-Myon
Publicado: (2016)

Authors’ reply to the comment from Benavides-Zora et al.
por: Kotani, Yuki, et al.
Publicado: (2023)

Reply to Comment on Peripheral Polyneuropathy Associated with COVID-19 in Two Patients: A Musculoskeletal Ultrasound Case Report
por: Soliman, Steven B.
Publicado: (2021)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
por: Kuenzig, M Ellen, et al.
Publicado: (2022)

Authors’ Reply to Critical Comment on “Vitamin D Level in Alopecia Areata”
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2018)

Reply to ‘Comment on ‘Anthropometric measurements and survival after prostate cancer diagnosis”
por: Farris, Megan S., et al.
Publicado: (2018)

Reply to Comment on An Intrauterine Gestational Sac Surrounded by Thin Myometrium at Fundus
por: Lai, Shih-Ting, et al.
Publicado: (2018)

Reply to Comment on Sonographic Evaluation of Abdominal Organs in Sickle Cell Disease
por: Luntsi, Geofery, et al.
Publicado: (2018)

Reply to comment on “Filler rhinoplasty based on anatomy: The dual plane technique”
por: Jung, Gyu Sik
Publicado: (2020)

Reply to Comment on “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
por: Guillemette, Chantal, et al.
Publicado: (2020)

Reply to: Comments on “Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma”
por: Li, Peng, et al.
Publicado: (2019)

COVID-19 vaccine efficacy data: solid enough to delay second dose? – Authors' reply
por: Amit, Sharon, et al.
Publicado: (2021)

Reply to Comments on Fetal Gestational Age Determination using Ultrasound Placental Thickness
por: Idowu, Bukunmi Michael
Publicado: (2022)

Reply to Comment on: The Impact of COVID-19 on Individuals Across the Spectrum of Visual Impairment
por: Shukla, Aakriti Garg, et al.
Publicado: (2021)

Reply to a Comment on “The Nature of Chalcogen‐Bonding‐Type Tellurium–Nitrogen Interactions”
por: Vishnevskiy, Yury V., et al.
Publicado: (2021)

Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
por: Prendecki, Maria, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

Reply to Mungmunpuntipantip and Wiwanitkit: CoronaVac or BNT162b2 Vaccine as a Third Dose
por: Mok, Chris Ka Pun, et al.
Publicado: (2022)

Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine
por: Peng, Pai, et al.
Publicado: (2021)

Reply to Expert Comments - A Study of Donor Area in Follicular Unit Hair Transplantation
por: Nirmal, Balakrishnan, et al.
Publicado: (2014)

Reply to “Comment on ‘On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens’”
por: Janesick, Amanda S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v9brdlmrrkfi265965c731qion